Credicorp Ltd.
Credicorp Ltd. (BAP) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Credicorp Ltd. (BAP), featuring income statements, balance sheets, and cash flow data.
Credicorp Ltd. (BAP) Income Statement & Financial Overview
Analyze Credicorp Ltd.’s BAP earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $6.93B | $6.61B | $5.47B | $5.42B |
| Cost of Revenue | $1.90B | $2.52B | $0.00 | $0.00 |
| Gross Profit | $5.03B | $4.09B | $4.60B | $4.26B |
| Gross Profit Ratio | $0.73 | $0.62 | $0.84 | $0.79 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.05B | $2.33B | $1.95B | $1.93B |
| Operating Expenses | $2.51B | $2.34B | $2.49B | $2.44B |
| Total Costs & Expenses | $4.41B | $4.85B | $2.35B | $2.39B |
| Interest Income | $4.87B | $5.00B | $4.98B | $4.93B |
| Interest Expense | $1.32B | $1.38B | $1.41B | $1.47B |
| Depreciation & Amortization | $203.77M | $186.63M | $179.50M | $172.20M |
| EBITDA | $2.72B | $1.94B | $2.29B | $2.06B |
| EBITDA Ratio | $0.39 | $0.29 | $0.42 | $0.38 |
| Operating Income | $2.52B | $2.67B | $2.11B | $1.89B |
| Operating Income Ratio | $0.36 | $0.40 | $0.39 | $0.35 |
| Other Income/Expenses (Net) | $0.00 | -$914.75M | $0.00 | $1.89B |
| Income Before Tax | $2.52B | $1.76B | $2.11B | $1.89B |
| Income Before Tax Ratio | $0.36 | $0.27 | $0.39 | $0.35 |
| Income Tax Expense | $704.47M | $598.35M | $555.12M | $519.34M |
| Net Income | $1.78B | $1.13B | $1.52B | $1.34B |
| Net Income Ratio | $0.26 | $0.17 | $0.28 | $0.25 |
| EPS | $22.40 | $14.14 | $19.14 | $16.84 |
| Diluted EPS | $22.40 | $14.14 | $19.16 | $16.84 |
| Weighted Avg Shares Outstanding | $79.37M | $79.67M | $79.43M | $79.31M |
| Weighted Avg Shares Outstanding (Diluted) | $79.37M | $79.67M | $79.43M | $79.31M |
The company's financials show resilient growth, with revenue advancing from $5.42B in Q2 2024 to $6.93B in Q1 2025. Gross profit remained healthy with margins at 73% in Q1 2025 compared to 79% in Q2 2024. Operating income hit $2.52B last quarter, sustaining a consistent 36% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.72B. Net income rose to $1.78B, while earnings per share reached $22.40. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan